K
Katrina J. Ruedy
Publications - 104
Citations - 9699
Katrina J. Ruedy is an academic researcher. The author has contributed to research in topics: Type 1 diabetes & Diabetes mellitus. The author has an hindex of 49, co-authored 96 publications receiving 8026 citations.
Papers
More filters
Journal ArticleDOI
Continuous glucose monitoring and intensive treatment of type 1 diabetes.
William V. Tamborlane,Roy W. Beck,Bruce W. Bode,Bruce A. Buckingham,Chase Hp,Robert Clemons,Rosanna Fiallo-Scharer,Larry A. Fox,Lisa K. Gilliam,Irl B. Hirsch,Elbert S. Huang,Kollman C,Kowalski Aj,Lori M.B. Laffel,Jean M. Lawrence,Joyce M. Lee,Nelly Mauras,Michael J. O'Grady,Katrina J. Ruedy,Michael Tansey,Eva Tsalikian,Stuart A. Weinzimer,Darrell M. Wilson,Howard Wolpert,T. Wysocki,Dongyuan Xing +25 more
TL;DR: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes and further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents.
Journal ArticleDOI
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W. Beck,Tonya D Riddlesworth,Katrina J. Ruedy,Andrew J. Ahmann,Richard M. Bergenstal,Stacie Haller,Craig Kollman,Davida F. Kruger,Janet B. McGill,William H. Polonsky,Elena Toschi,Howard Wolpert,David Price +12 more
TL;DR: Among adults with type 1 diabetes who used multiple daily insulin injections, the use of CGM compared with usual care resulted in a greater decrease in HbA1c level during 24 weeks.
Journal ArticleDOI
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
Denice S. Feig,Denice S. Feig,Lois E. Donovan,Rosa Corcoy,Kellie E. Murphy,Kellie E. Murphy,Stephanie A. Amiel,Katharine F. Hunt,Katharine F. Hunt,Elizabeth Asztalos,Jon Barrett,J. Johanna Sanchez,Alberto de Leiva,Moshe Hod,Lois Jovanovic,Lois Jovanovic,Erin Keely,Ruth McManus,Eileen K. Hutton,Claire L Meek,Zoe A. Stewart,Tim Wysocki,Robert O'Brien,Katrina J. Ruedy,Craig Kollman,George Tomlinson,George Tomlinson,Helen R. Murphy,Helen R. Murphy,Helen R. Murphy,Jeannie Grisoni,Carolyn Byrne,Katy Davenport,Sandra L. Neoh,Claire Gougeon,Carolyn Oldford,Catherine Young,Louisa Green,Benedetta Rossi,Helen Rogers,Barbara Cleave,Michelle Strom,J. M. Adelantado,Ana Chico,Diana Tundidor,Janine Malcolm,Kathy Henry,Damian Morris,Gerry Rayman,Duncan Fowler,Susan Mitchell,Josephine Rosier,R. C. Temple,Jeremy Turner,Gioia Canciani,Niranjala M Hewapathirana,Leanne Piper,Anne Kudirka,Margaret Watson,Matteo Bonomo,Basilio Pintaudi,Federico Bertuzzi,Giuseppina Daniela,Elena Mion,Julia Lowe,Ilana Halperin,Anna Rogowsky,Sapida Adib,Robert S. Lindsay,David M. Carty,Isobel Crawford,Fiona Mackenzie,Therese McSorley,J. D. Booth,Natalia McInnes,Ada Smith,Irene Stanton,Tracy Tazzeo,John Weisnagel,Peter Mansell,Nia Jones,Gayna Babington,Dawn Spick,Malcolm MacDougall,Sharon Chilton,Terri Cutts,Michelle Perkins,Eleanor Scott,Del Endersby,Anna Dover,Frances Dougherty,Susan Johnston,Simon Heller,Peter Novodorsky,Sue Hudson,Chloe Nisbet,Thomas Ransom,Jill Coolen,Darlene Baxendale,Richard I. G. Holt,Jane Forbes,Nicki Martin,Fiona Walbridge,Fidelma Dunne,Sharon Conway,Aoife M. Egan,Collette Kirwin,Michael Maresh,Gretta Kearney,Juliet Morris,Susan J. Quinn,Rudy Bilous,Rasha Mukhtar,Ariane Godbout,Sylvie Daigle,Alexandra Lubina,Margaret Hadley Jackson,Emma Paul,Julie Taylor,Robyn L. Houlden,Robyn L. Houlden,Adriana Breen,Adriana Breen,Anita Banerjee,Anna Brackenridge,Annette Briley,Anna Reid,Claire Singh,Jill Newstead-Angel,Janet Baxter,Sam Philip,Martyna Chlost,Lynne Murray,Kristin Castorino,Donna Frase,Olivia Lou,Marlon Pragnell +136 more
TL;DR: In this paper, the effectiveness of continuous glucose monitoring (CGM) on maternal glucose control and obstetric and neonatal health outcomes was examined in women with Type 1 diabetes and planning pregnancy.
Journal ArticleDOI
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
Roy W. Beck,Tonya D Riddlesworth,Katrina J. Ruedy,Andrew J Ahmann,Stacie Haller,Davida F. Kruger,Janet B. McGill,William H. Polonsky,David C. Price,Stephen Aronoff,Ronnie Aronson,Elena Toschi,Craig Kollman,Richard M Bergenstal +13 more
TL;DR: A high percentage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved glycemic control, and these results support an additional management method that may benefit patients.
Journal ArticleDOI
The effect of continuous glucose monitoring in well-controlled type 1 diabetes.
Roy W. Beck,Irl B. Hirsch,Lori M.B. Laffel,William V. Tamborlane,Bruce W. Bode,Bruce A. Buckingham,Peter Chase,Robert Clemons,Rosanna Fiallo-Scharer,Larry A. Fox,Lisa K. Gilliam,Elbert S. Huang,Craig Kollman,Aaron J. Kowalski,Jean M. Lawrence,Joyce M. Lee,Nelly Mauras,Michael J. O'Grady,Katrina J. Ruedy,Michael Tansey,Eva Tsalikian,Stuart A. Weinzimer,Darrell M. Wilson,Howard Wolpert,Tim Wysocki,Dongyuan Xing +25 more
TL;DR: The weight of evidence suggests that CGM is beneficial for individuals with type 1 diabetes who have already achieved excellent control with A1C <7.0% and most outcomes, including those combining A 1C and hypoglycemia, favored the CGM group.